Detailed guides to painful problems, treatments & moresitemap

“Right-to-try” is the opposite of science-based medicine 

 •  • by Paul Ingraham
Get posts in your inbox:
A weekly nugget or two of pain science news and ideas for patients and pros, usually 400–1000 words. The blog is the “director’s commentary” on the core content of PainScience.com: a library of major articles and books about common painful problems and popular treatments. See the blog archives or updates for the whole site.

H.R. 1010 and s.204, the “right-to-try” laws, will endorse and protect quackery and snake oil in general, and allow pharmaceutical companies to sell unproven products. So the opposite of science-based medicine. Dr. David Gorski:

‘Right-to-try’ laws are a cruel sham that purport to allow terminally ill patients access to promising experimental drugs. In reality, they strip away many protections and leave vulnerable patients on their own.

And the Treatment Action Group’s #StopRTT page:

These acts offer only false hope: they won’t do anything to compel companies to make their experimental drugs and devices available pre-approval. Instead, they would allow companies to sell investigational drugs and devices to the public before they have demonstrated their safety and efficacy, or gone through the U.S. Food and Drug Administration (FDA) approval process.

PainSci Member Login » Submit your email to unlock member content. If you can’t remember/access your registration email, please contact me. ~ Paul Ingraham, PainSci Publisher